Related Experiment Video
Updated: May 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Sickle cell disease in children
Emily Riehm Meier1, Jeffery L Miller
1Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Insights
Newborn screening for sickle cell disease (SCD) and early interventions like penicillin and hydroxyurea have improved survival and reduced complications in children. Genetic therapies offer future prevention and cures for SCD.
Area of Science:
- Pediatrics
- Hematology
- Genetics
Background:
- Newborn screening for sickle cell disease (SCD) is now universal in the US.
- Early identification improves survival by preventing sepsis with prophylactic penicillin.
- Key complications in pediatric SCD include stroke, painful crises, and acute chest syndrome.
Purpose of the Study:
- To review clinical manifestations and therapeutic strategies for pediatric SCD.
- To discuss the evolving role of gene-focused prevention and therapy for SCD.
Main Methods:
- Review of existing literature on pediatric sickle cell disease management.
- Analysis of current and emerging therapeutic strategies, including genetic research.
Main Results:
- Universal newborn screening and early penicillin prophylaxis significantly reduce sepsis-related mortality.
- Transcranial Doppler screening and chronic transfusions decrease stroke risk from 10% to 1%.
- Hydroxyurea therapy reduces painful crises, acute chest syndromes, and transfusion needs.
Conclusions:
- Current management strategies have markedly improved outcomes for children with SCD.
- Ongoing genetic research holds promise for the ultimate prevention and cure of SCD.
- Focus is shifting towards long-term prevention and curative gene-based therapies for SCD.
Abstract:
Early identification of infants with sickle cell disease (SCD) by newborn screening, now universal in all 50 states in the US, has improved survival, mainly by preventing overwhelming sepsis with the early use of prophylactic penicillin. Routine transcranial Doppler screening with the institution of chronic transfusion decreases the risk of stroke from 10% to 1% in paediatric SCD patients. Hydroxyurea decreases the number and frequency of painful crises, acute chest syndromes and number of blood transfusions in children with SCD. Genetic research continues to be driven toward the prevention and ultimate cure of SCD before adulthood. This review focuses on clinical manifestations and therapeutic strategies for paediatric SCD as well as the evolving topic of gene-focused prevention and therapy.
Related Concept Videos
Multiple Allele Traits
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Chronic Kidney Disease II: Clinical Manifestations
iPS Cell Differentiation
